AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial
Authors: Furst, DE Clements, PJ Wong, WK Mayes, MD Wigley, F White, B Weisman, M Barr, W Moreland, L Martin, R Medsger, TA Steen, V Collier, D Weinstein, A Lally, E Varga, J Weiner, SR Andrews, B Abeles, M Peter, JB Seibold, JR
Citation: De. Furst et al., Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial, RHEUMATOLOG, 40(6), 2001, pp. 615-622
Surgery for ischemic pain and Raynaud's' phenomenon in scleroderma: A description of treatment protocol and evaluation of results
Authors: Tomaino, MM Goitz, RJ Medsger, TA
Citation: Mm. Tomaino et al., Surgery for ischemic pain and Raynaud's' phenomenon in scleroderma: A description of treatment protocol and evaluation of results, MICROSURG, 21(3), 2001, pp. 75-79
Criteria for the classification of early Systemic Sclerosis
Authors: LeRoy, EC Medsger, TA
Citation: Ec. Leroy et Ta. Medsger, Criteria for the classification of early Systemic Sclerosis, J RHEUMATOL, 28(7), 2001, pp. 1573-1576
D-penicillamine in systemic sclerosis? Yes!
Authors: Medsger, TA Lucas, M Wildy, KS Baker, C
Citation: Ta. Medsger et al., D-penicillamine in systemic sclerosis? Yes!, SC J RHEUM, 30(4), 2001, pp. 192-194
Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis
Authors: Kuwana, M Feghali, CA Medsger, TA Wright, TM
Citation: M. Kuwana et al., Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis, ARTH RHEUM, 44(7), 2001, pp. 1654-1659
Systemic sclerosis with renal crisis and pulmonary hypertension - A reportof eleven cases
Authors: Gunduz, OH Fertig, N Lucas, M Medsger, TA
Citation: Oh. Gunduz et al., Systemic sclerosis with renal crisis and pulmonary hypertension - A reportof eleven cases, ARTH RHEUM, 44(7), 2001, pp. 1663-1666
The Disability Index of the Health Assessment Questionnaire is a predictorand correlate of outcome in the high-dose versus low-dose penicillamine insystemic sclerosis trial
Authors: Clements, PJ Wong, WK Hurwitz, EL Furst, DE Mayes, M White, B Wigley, F Weisman, M Barr, W Moreland, L Medsger, TA Steen, V Martin, RW Collier, D Weinstein, A Lally, E Varga, J Weiner, SR Andrews, B Abeles, M Seibold, JR
Citation: Pj. Clements et al., The Disability Index of the Health Assessment Questionnaire is a predictorand correlate of outcome in the high-dose versus low-dose penicillamine insystemic sclerosis trial, ARTH RHEUM, 44(3), 2001, pp. 653-661
Improvement in skin thickening in systemic sclerosis associated with improved survival
Authors: Steen, VD Medsger, TA
Citation: Vd. Steen et Ta. Medsger, Improvement in skin thickening in systemic sclerosis associated with improved survival, ARTH RHEUM, 44(12), 2001, pp. 2828-2835
Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome
Authors: Hertzman, PA Clauw, DJ Duffy, J Medsger, TA Feinstein, AR
Citation: Pa. Hertzman et al., Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome, ARCH IN MED, 161(19), 2001, pp. 2301-2306
Assessment of damage and activity in systemic sclerosis
Authors: Medsger, TA
Citation: Ta. Medsger, Assessment of damage and activity in systemic sclerosis, CURR OP RH, 12(6), 2000, pp. 545-548
The Lupus Foundation as an additional source for case ascertainment: Developing a community-based lupus registry
Authors: Fitzgerald, SG Kwoh, CK McCarty, D Ramsey-Goldman, R Medsger, TA Manzi, S
Citation: Sg. Fitzgerald et al., The Lupus Foundation as an additional source for case ascertainment: Developing a community-based lupus registry, ARTH C RES, 13(3), 2000, pp. 137-140
Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin)
Authors: Falkner, D Wilson, J Fertig, N Clawson, K Medsger, TA Morel, PA
Citation: D. Falkner et al., Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin), J RHEUMATOL, 27(5), 2000, pp. 1196-1202
Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins
Authors: Vaughan, JH Shaw, PX Nguyen, MD Medsger, TA Wright, TM Metcalf, JS Leroy, EC
Citation: Jh. Vaughan et al., Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins, J RHEUMATOL, 27(3), 2000, pp. 821-823
Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange
Authors: Ferri, C Emdin, M Storino, FAA Giuggioli, D Longombardo, G Greco, F Fertig, N Medsger, TA
Citation: C. Ferri et al., Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange, SC J RHEUM, 29(3), 2000, pp. 198-200
Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells
Authors: Kuwana, M Medsger, TA Wright, TM
Citation: M. Kuwana et al., Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells, J IMMUNOL, 164(12), 2000, pp. 6138-6146
Approaches for identifying and defining environmentally associated rheumatic disorders
Authors: Miller, FW Hess, EV Clauw, DJ Hertzman, PA Pincus, T Silver, RM Mayes, MD Varga, J Medsger, TA Love, LA
Citation: Fw. Miller et al., Approaches for identifying and defining environmentally associated rheumatic disorders, ARTH RHEUM, 43(2), 2000, pp. 243-249
Systemic sclerosis sine scleroderma - Demographic, clinical, and serologicfeatures and survival in forty-eight patients
Authors: Poormoghim, H Lucas, M Fertig, N Medsger, TA
Citation: H. Poormoghim et al., Systemic sclerosis sine scleroderma - Demographic, clinical, and serologicfeatures and survival in forty-eight patients, ARTH RHEUM, 43(2), 2000, pp. 444-451
Severe organ involvement in systemic sclerosis with diffuse scleroderma
Authors: Steen, VD Medsger, TA
Citation: Vd. Steen et Ta. Medsger, Severe organ involvement in systemic sclerosis with diffuse scleroderma, ARTH RHEUM, 43(11), 2000, pp. 2437-2444
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis - High-dose versus low-dose penicillamine trial
Authors: Clements, PJ Hurwitz, EL Wong, WK Seibold, JR Mayes, M White, B Wigley, F Weisman, M Barr, W Moreland, L Medsger, TA Steen, VD Martin, RW Collier, D Weinstein, A Lally, E Varga, J Weiner, SR Andrews, B Abeles, M Furst, DE
Citation: Pj. Clements et al., Skin thickness score as a predictor and correlate of outcome in systemic sclerosis - High-dose versus low-dose penicillamine trial, ARTH RHEUM, 43(11), 2000, pp. 2445-2454
Long-term outcomes of scleroderma renal crisis
Authors: Steen, VD Medsger, TA
Citation: Vd. Steen et Ta. Medsger, Long-term outcomes of scleroderma renal crisis, ANN INT MED, 133(8), 2000, pp. 600-603
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial
Authors: Badesch, DB Tapson, VF McGoon, MD Brundage, BH Rubin, LJ Wigley, FM Rich, S Barst, RJ Barrett, PS Kral, KM Jobsis, MM Loyd, JE Murali, S Frost, A Girgis, R Bourge, RC Ralph, DD Elliott, CG Hill, NS Langleben, D Schilz, RJ McLaughlin, VV Robbins, IM Groves, BM Shapiro, S Medsger, TA Gaine, SP Horn, E Decker, JC Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425
A disease severity scale for systemic sclerosis: Development and testing
Authors: Medsger, TA Silman, AJ Steen, VD Black, CM Akesson, A Bacon, PA Harris, CA Jablonska, S Jayson, MIV Jimenez, SA Krieg, T Leroy, EC Maddison, PJ Russell, ML Schachter, RK Wollheim, FA Zacharaie, H
Citation: Ta. Medsger et al., A disease severity scale for systemic sclerosis: Development and testing, J RHEUMATOL, 26(10), 1999, pp. 2159-2167
An immunodominant epitope on DNA topoisomerase I is conformational in nature - Heterogeneity in its recognition by systemic sclerosis sera
Authors: Kuwana, M Kaburaki, J Medsger, TA Wright, TM
Citation: M. Kuwana et al., An immunodominant epitope on DNA topoisomerase I is conformational in nature - Heterogeneity in its recognition by systemic sclerosis sera, ARTH RHEUM, 42(6), 1999, pp. 1179-1188
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis - Analysis of a two-year, double-blind, randomized, controlled clinicaltrial
Authors: Clements, PJ Furst, DE Wong, WK Mayes, M White, B Wigley, F Weisman, MH Barr, W Moreland, LW Medsger, TA Steen, V Martin, RW Collier, D Weinstein, A Lally, E Varga, J Weiner, S Andrews, B Abeles, M Seibold, JR
Citation: Pj. Clements et al., High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis - Analysis of a two-year, double-blind, randomized, controlled clinicaltrial, ARTH RHEUM, 42(6), 1999, pp. 1194-1203
Fertility and pregnancy outcome in women with systemic sclerosis
Authors: Steen, VD Medsger, TA
Citation: Vd. Steen et Ta. Medsger, Fertility and pregnancy outcome in women with systemic sclerosis, ARTH RHEUM, 42(4), 1999, pp. 763-768
Risultati: 1-25 | 26-29